Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “PROTON”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18
All sourcesNASA NTRSDOE OSTI
DOE OSTI2016

Sci-Fri PM: Radiation Therapy, Planning, Imaging, and Special Techniques - 01: On the use of proton radiography to reduce beam range uncertainties and improve patient positioning accuracy in proton therapy

To present two related developments of proton radiography (pRad) to minimize range uncertainty in proton therapy. The first combines a pRad with an X-ray CT to produce a patient-specific relative stopping power (RSP) map. The second aims to improve the pRad spatial resolution for accurate registration prior to the first. The enhanced-pRad can also be used in a novel proton-CT reconstruction algorithm. Monte Carlo pRad were computed from three phantoms; the Gammex, the Catphan and an anthropomorphic head. An optimized cubic-spline estimator derives the most likely path. The length crossed by the protons voxel-by-voxel was calculated by combining their estimated paths with the CT. The difference between the theoretical (length×RSP) and measured energy loss was minimized through a least squares optimization (LSO) algorithm yielding the RSP map. To increase pRad spatial resolution for registration with the CT, the phantom was discretized into voxels columns. The average column RSP was optimized to maximize the proton energy loss likelihood (MLE). Simulations showed precise RSP (<0.75%) for Gammex materials except low-density lung (<1.2%). For the head, accurate RSP were obtained (µ=−0.10%1.5σ=1.12%) and the range precision was improved (ΔR80 of −0.20±0.35%). Spatial resolution was increased in pRad (2.75 to 6.71 lp/cm) and pCT from MLE-enhanced pRad (2.83 to 5.86 lp/cm). The LSO decreases the range uncertainty (R80σ<1.0%) while the MLE-enhanced pRad spatial resolution (+244%) and is a great candidate for pCT reconstruction.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

On the possibility for precision measurements of differential cross sections for elastic proton–proton scattering at the Protvino accelerator

Elastic-scattering data were analyzed, and it was concluded on the basis of this analysis that precisionmeasurements of differential cross sections for elastic proton–proton scattering at the accelerator of the Institute for High Energy Physics (IHEP, Protvino, Russia) over a broad momentum-transfer range are of importance and topical interest. The layout of the respective experimental facility detecting the scattered particle and recoil proton and possessing a high momentum-transfer resolution was examined along with the equipment constituting this facility. The facility in question is able to record up to a billion events of elastic proton–proton scattering per IHEP accelerator run (20 days). Other lines of physics research with this facility are briefly discussed.

74 ATOMIC AND MOLECULAR PHYSICS↗
DOE OSTI2015

Studies of a proton phase beam monitor for range verification in proton therapy

A primary subject of the present research in particle therapy is to ensure the precise irradiation of the target volume. The prompt gamma timing (PGT) method provides one possibility for in vivo range verification during the irradiation of patients. Prompt gamma rays with high energies are emitted promptly due to nuclear reactions of protons with tissue. The arrival time of these gammas to the detector reflects the stopping process of the primary protons in tissue and are directly correlated to the range. Due to the time resolution of the detector and the proton bunch time spread, as well as drifts of the bunch phase with respect to the accelerator frequency, timing spectra are smeared out and compromise the accuracy of range information intended for future clinical applications. Nevertheless, counteracting this limitation and recovering range information from the PGT measured spectra, corrections using a phase beam monitor can be performed. A first prototype of phase beam monitor was tested at GSI Darmstadt, where measurements of the energy profile of the ion bunches were performed. At the ELBE accelerator Helmholtz-Zentrum Dresden-Rossendorf (HZDR), set up to provide bremsstrahlung photons in very short pulses, a constant fraction algorithm for the incoming digital signals was evaluated, which is used for optimizing the time resolution. Studies of scattering experiments with different thin targets and detector positions are accomplished at Oncoray Dresden, where a clinical proton beam is available. These experiments allow a basic characterization of the proton bunch structure and the detection yield. (authors)

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2012

A detection system for very low-energy protons from {beta}-delayed proton decay

We have recently developed a gas based detection system called AstroBox, motivated by nuclear astrophysics studies. The goal was to detect very low-energy protons from {beta}-delayed p-decay with reduced beta background and improved energy resolution. The detector was tested using the {beta}-delayed proton-emitter 23Al previously studied with a set-up based on thin double-sided Si strip detectors. The proton spectrum obtained with AstroBox showed no beta background down to {approx}80 keV. The low energy (206 keV, 267 keV) proton peaks were positively identified, well separated, and the resolution was improved.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2015

High temperature proton exchange membranes with enhanced proton conductivities at low humidity and high temperature based on polymer blends and block copolymers of poly(1,3-cyclohexadiene) and poly(ethylene glycol)

Hot (at 120 °C) and dry (20% relative humidity) operating conditions benefit fuel cell designs based on proton exchange membranes (PEMs) and hydrogen due to simplified system design and increasing tolerance to fuel impurities. In this paper, presented are preparation, partial characterization, and multi-scale modeling of such PEMs based on cross-linked, sulfonated poly(1,3-cyclohexadiene) (xsPCHD) blends and block copolymers with poly(ethylene glycol) (PEG). These low cost materials have proton conductivities 18 times that of current industry standard Nafion at hot, dry operating conditions. Among the membranes studied, the blend xsPCHD-PEG PEM displayed the highest proton conductivity, which exhibits a morphology with higher connectivity of the hydrophilic domain throughout the membrane. Simulation and modeling provide a molecular level understanding of distribution of PEG within this hydrophilic domain and its relation to proton conductivities. Finally, this study demonstrates enhancement of proton conductivity at high temperature and low relative humidity by incorporation of PEG and optimized sulfonation conditions.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗
DOE OSTI2014

SU-E-J-175: Proton Dose Calculation On Scatter-Corrected CBCT Image: Feasibility Study for Adaptive Proton Therapy

Purpose: To demonstrate feasibility of proton dose calculation on scattercorrected CBCT images for the purpose of adaptive proton therapy. Methods: Two CBCT image sets were acquired from a prostate cancer patient and a thorax phantom using an on-board imaging system of an Elekta infinity linear accelerator. 2-D scatter maps were estimated using a previously introduced CT-based technique, and were subtracted from each raw projection image. A CBCT image set was then reconstructed with an open source reconstruction toolkit (RTK). Conversion from the CBCT number to HU was performed by soft tissue-based shifting with reference to the plan CT. Passively scattered proton plans were simulated on the plan CT and corrected/uncorrected CBCT images using the XiO treatment planning system. For quantitative evaluation, water equivalent path length (WEPL) was compared in those treatment plans. Results: The scatter correction method significantly improved image quality and HU accuracy in the prostate case where large scatter artifacts were obvious. However, the correction technique showed limited effects on the thorax case that was associated with fewer scatter artifacts. Mean absolute WEPL errors from the plans with the uncorrected and corrected images were 1.3 mm and 5.1 mm in the thorax case and 13.5 mm and 3.1 mm in the prostate case. The prostate plan dose distribution of the corrected image demonstrated better agreement with the reference one than that of the uncorrected image. Conclusion: A priori CT-based CBCT scatter correction can reduce the proton dose calculation error when large scatter artifacts are involved. If scatter artifacts are low, an uncorrected CBCT image is also promising for proton dose calculation when it is calibrated with the soft-tissue based shifting.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2014

MO-A-BRD-10: A Fast and Accurate GPU-Based Proton Transport Monte Carlo Simulation for Validating Proton Therapy Treatment Plans

Purpose: To build a GPU-based Monte Carlo (MC) simulation of proton transport with detailed modeling of elastic and non-elastic (NE) protonnucleus interactions, for use in a very fast and cost-effective proton therapy treatment plan verification system. Methods: Using the CUDA framework, we implemented kernels for the following tasks: (1) Simulation of beam spots from our possible scanning nozzle configurations, (2) Proton propagation through CT geometry, taking into account nuclear elastic and multiple scattering, as well as energy straggling, (3) Bertini-style modeling of the intranuclear cascade stage of NE interactions, and (4) Simulation of nuclear evaporation. To validate our MC, we performed: (1) Secondary particle yield calculations in NE collisions with therapeutically-relevant nuclei, (2) Pencil-beam dose calculations in homogeneous phantoms, (3) A large number of treatment plan dose recalculations, and compared with Geant4.9.6p2/TOPAS. A workflow was devised for calculating plans from a commercially available treatment planning system, with scripts for reading DICOM files and generating inputs for our MC. Results: Yields, energy and angular distributions of secondaries from NE collisions on various nuclei are in good agreement with the Geant4.9.6p2 Bertini and Binary cascade models. The 3D-gamma pass rate at 2%–2mm for 70–230 MeV pencil-beam dose distributions in water, soft tissue, bone and Ti phantoms is 100%. The pass rate at 2%–2mm for treatment plan calculations is typically above 98%. The net computational time on a NVIDIA GTX680 card, including all CPU-GPU data transfers, is around 20s for 1×10{sup 7} proton histories. Conclusion: Our GPU-based proton transport MC is the first of its kind to include a detailed nuclear model to handle NE interactions on any nucleus. Dosimetric calculations demonstrate very good agreement with Geant4.9.6p2/TOPAS. Our MC is being integrated into a framework to perform fast routine clinical QA of pencil-beam treatment plans. Hardware for such a system will cost under $5000. This work was funded in part by a grant from Varian Medical Systems, Inc.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2014

The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions

Purpose: Proton radiotherapy allows radiation treatment delivery with high dose gradients. The nature of such dose distributions increases the influence of patient positioning uncertainties on their fidelity when compared to photon radiotherapy. The present work quantitatively analyzes the influence of setup uncertainties on proton range and dose distributions. Methods: Thirty-eight clinical passive scattering treatment fields for small lesions in the head were studied. Dose distributions for shifted and rotated patient positions were Monte Carlo-simulated. Proton range uncertainties at the 50%- and 90%-dose falloff position were calculated considering 18 arbitrary combinations of maximal patient position shifts and rotations for two patient positioning methods. Normal tissue complication probabilities (NTCPs), equivalent uniform doses (EUDs), and tumor control probabilities (TCPs) were studied for organs at risk (OARs) and target volumes of eight patients. Results: The authors identified a median 1σ proton range uncertainty at the 50%-dose falloff of 2.8 mm for anatomy-based patient positioning and 1.6 mm for fiducial-based patient positioning as well as 7.2 and 5.8 mm for the 90%-dose falloff position, respectively. These range uncertainties were correlated to heterogeneity indices (HIs) calculated for each treatment field (38% < R{sup 2} < 50%). A NTCP increase of more than 10% (absolute) was observed for less than 2.9% (anatomy-based positioning) and 1.2% (fiducial-based positioning) of the studied OARs and patient shifts. For target volumes TCP decreases by more than 10% (absolute) occurred in less than 2.2% of the considered treatment scenarios for anatomy-based patient positioning and were nonexistent for fiducial-based patient positioning. EUD changes for target volumes were up to 35% (anatomy-based positioning) and 16% (fiducial-based positioning). Conclusions: The influence of patient positioning uncertainties on proton range in therapy of small lesions in the human brain as well as target and OAR dosimetry were studied. Observed range uncertainties were correlated with HIs. The clinical practice of using multiple fields with smeared compensators while avoiding distal OAR sparing is considered to be safe.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2014

Benchmarking of a treatment planning system for spot scanning proton therapy: Comparison and analysis of robustness to setup errors of photon IMRT and proton SFUD treatment plans of base of skull meningioma

Purpose: Base of skull meningioma can be treated with both intensity modulated radiation therapy (IMRT) and spot scanned proton therapy (PT). One of the main benefits of PT is better sparing of organs at risk, but due to the physical and dosimetric characteristics of protons, spot scanned PT can be more sensitive to the uncertainties encountered in the treatment process compared with photon treatment. Therefore, robustness analysis should be part of a comprehensive comparison between these two treatment methods in order to quantify and understand the sensitivity of the treatment techniques to uncertainties. The aim of this work was to benchmark a spot scanning treatment planning system for planning of base of skull meningioma and to compare the created plans and analyze their robustness to setup errors against the IMRT technique. Methods: Plans were produced for three base of skull meningioma cases: IMRT planned with a commercial TPS [Monaco (Elekta AB, Sweden)]; single field uniform dose (SFUD) spot scanning PT produced with an in-house TPS (PSI-plan); and SFUD spot scanning PT plan created with a commercial TPS [XiO (Elekta AB, Sweden)]. A tool for evaluating robustness to random setup errors was created and, for each plan, both a dosimetric evaluation and a robustness analysis to setup errors were performed. Results: It was possible to create clinically acceptable treatment plans for spot scanning proton therapy of meningioma with a commercially available TPS. However, since each treatment planning system uses different methods, this comparison showed different dosimetric results as well as different sensitivities to setup uncertainties. The results confirmed the necessity of an analysis tool for assessing plan robustness to provide a fair comparison of photon and proton plans. Conclusions: Robustness analysis is a critical part of plan evaluation when comparing IMRT plans with spot scanned proton therapy plans.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2015

Proton dose calculation on scatter-corrected CBCT image: Feasibility study for adaptive proton therapy

Purpose: To demonstrate the feasibility of proton dose calculation on scatter-corrected cone-beam computed tomographic (CBCT) images for the purpose of adaptive proton therapy. Methods: CBCT projection images were acquired from anthropomorphic phantoms and a prostate patient using an on-board imaging system of an Elekta infinity linear accelerator. Two previously introduced techniques were used to correct the scattered x-rays in the raw projection images: uniform scatter correction (CBCT{sub us}) and a priori CT-based scatter correction (CBCT{sub ap}). CBCT images were reconstructed using a standard FDK algorithm and GPU-based reconstruction toolkit. Soft tissue ROI-based HU shifting was used to improve HU accuracy of the uncorrected CBCT images and CBCT{sub us}, while no HU change was applied to the CBCT{sub ap}. The degree of equivalence of the corrected CBCT images with respect to the reference CT image (CT{sub ref}) was evaluated by using angular profiles of water equivalent path length (WEPL) and passively scattered proton treatment plans. The CBCT{sub ap} was further evaluated in more realistic scenarios such as rectal filling and weight loss to assess the effect of mismatched prior information on the corrected images. Results: The uncorrected CBCT and CBCT{sub us} images demonstrated substantial WEPL discrepancies (7.3 ± 5.3 mm and 11.1 ± 6.6 mm, respectively) with respect to the CT{sub ref}, while the CBCT{sub ap} images showed substantially reduced WEPL errors (2.4 ± 2.0 mm). Similarly, the CBCT{sub ap}-based treatment plans demonstrated a high pass rate (96.0% ± 2.5% in 2 mm/2% criteria) in a 3D gamma analysis. Conclusions: A priori CT-based scatter correction technique was shown to be promising for adaptive proton therapy, as it achieved equivalent proton dose distributions and water equivalent path lengths compared to those of a reference CT in a selection of anthropomorphic phantoms.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2016

TH-CD-209-10: Scanning Proton Arc Therapy (SPArc) - The First Robust and Delivery-Efficient Spot Scanning Proton Arc Therapy

Purpose: To develop a delivery-efficient proton spot-scanning arc therapy technique with robust plan quality. Methods: We developed a Scanning Proton Arc(SPArc) optimization algorithm integrated with (1)Control point re-sampling by splitting control point into adjacent sub-control points; (2)Energy layer re-distribution by assigning the original energy layers to the new sub-control points; (3)Energy layer filtration by deleting low MU weighting energy layers; (4)Energy layer re-sampling by sampling additional layers to ensure the optimal solution. A bilateral head and neck oropharynx case and a non-mobile lung target case were tested. Plan quality and total estimated delivery time were compared to original robust optimized multi-field step-and-shoot arc plan without SPArc optimization (Arcmulti-field) and standard robust optimized Intensity Modulated Proton Therapy(IMPT) plans. Dose-Volume-Histograms (DVH) of target and Organ-at-Risks (OARs) were analyzed along with all worst case scenarios. Total delivery time was calculated based on the assumption of a 360 degree gantry room with 1 RPM rotation speed, 2ms spot switching time, beam current 1nA, minimum spot weighting 0.01 MU, energy-layer-switching-time (ELST) from 0.5 to 4s. Results: Compared to IMPT, SPArc delivered less integral dose(−14% lung and −8% oropharynx). For lung case, SPArc reduced 60% of skin max dose, 35% of rib max dose and 15% of lung mean dose. Conformity Index is improved from 7.6(IMPT) to 4.0(SPArc). Compared to Arcmulti-field, SPArc reduced number of energy layers by 61%(276 layers in lung) and 80%(1008 layers in oropharynx) while kept the same robust plan quality. With ELST from 0.5s to 4s, it reduced 55%–60% of Arcmulti-field delivery time for the lung case and 56%–67% for the oropharynx case. Conclusion: SPArc is the first robust and delivery-efficient proton spot-scanning arc therapy technique which could be implemented in routine clinic. For modern proton machine with ELST close to 0.5s, SPArc would be a popular treatment option for both single and multi-room center.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2013

Measurement of the inelastic proton-proton cross section with the ATLAS detector

A measurement of the inelastic proton-proton cross-section at centre-of-mass energy of Central diffraction in proton-proton collisions at {radical}(s) = 7TeV using the ATLAS detector at the Large Hadron Collider is presented. Events are selected by requiring hits in scintillator counters mounted in the forward region of the ATLAS detector and the dataset corresponding to an integrated luminosity of 20{mu}b{sup -1}. In addition, the total cross-section is studied as a function of the rapidity gap size measured with the inner detector and calorimetry.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2019

Constraining unintegrated gluon distributions from inclusive photon production in proton–proton collisions at the LHC

We compute the leading order (LO) qg → qγ and next-to-leading order (NLO) gg → qq¯γ contributions to inclusive photon production in proton–proton (p+p) collisions at the LHC. These channels provide the dominant contribution at LO and NLO for photon transverse momenta k γ⟂ corresponding to momentum fractions of x ≤ 0.01 in the colliding protons. Our computations, performed in the dilute–dense framework of the Color Glass Condensate effective field theory (CGC EFT), show that the NLO contribution dominates at small-x because it is sensitive to k γ⟂ -dependent unintegrated gluon distributions in both of the protons. We predict a maximal 10% modification of the cross section at low k γ⟂ as a direct consequence of the violation of k ⟂ -factorization. The coherence effects responsible for this modification are enhanced in nuclei and can be identified from inclusive photon measurements in proton–nucleus collisions. We provide numerical results for the isolated inclusive photon cross section for k γ⟂ ≤ 20 GeV in p+p collisions that can be tested in the future at the LHC.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗
DOE OSTI2015

Molecular Electrocatalysts for Oxidation of Hydrogen Using Earth-Abundant Metals: Shoving Protons Around with Proton Relays

Sustainable, carbon-neutral energy is needed to supplant the worldwide reliance on fossil fuels, to address the persistent problem of increasing emissions of CO 2 . Solar and wind energy are intermittent, highlighting the need to develop energy storage on a huge scale. Electrocatalysts provide a way to convert between electrical energy generated by renewable energy sources and chemical energy in the form of chemical bonds. Here, the oxidation of hydrogen to give two electrons and two protons is carried out in fuel cells, but the typical catalyst is platinum, a precious metal of low earth-abundance and high cost. In nature, hydrogenases based on iron or iron/nickel reversibly oxidize hydrogen with remarkable efficiency and rates. Functional models of these enzymes are synthesized with the goal of achieving electrocatalytic H 2 oxidation using inexpensive, earth-abundant metals along with a key feature identified in the [FeFe]-hydrogenase: an amine base positioned near the metal. The diphosphine ligands P R 2 N R' 2 (1,5-diaza-3,7-diphosphacyclooctane with alkyl or aryl groups on the P and N) are used as ligands in Ni, Fe and Mn complexes. The pendant amines promote binding and heterolytic cleavage of H 2 , placing the hydride on the metal and the proton on the amine. The pendant amines also serve as proton relays, accelerating intramolecular and intermolecular proton transfers. Electrochemical oxidations and deprotonations by an exogeneous amine base lead to catalytic cycles for oxidation of H 2 (1 atm) at room temperature for catalysts derived from [Ni(P Cy 2 N R' 2 ) 2 ] 2+ , Cp C6F5 Fe(P tBu 2 N Bn 2 )H and MnH(P Ph 2 N Bn 2 )(bppm)(CO) [bppm = (PAr F 2 ) 2 CH 2 )]. The Mn cation [Mn(P Ph 2 N Bn 2 )(bppm)(CO)] + mediates the rapid (>10 4 s -1 at -95 °C), reversible heterolytic cleavage of H 2 . Obtaining the optimal benefit of pendant amines incorporated into the ligand requires that the pendant amine be properly positioned to interact with a M-H or M(H 2 ) bond. In addition, ligands are ideally selected such that the hydride acceptor ability of the metal and the basicity of a pendant are tuned to give low barriers for heterolytic cleavage of the H-H bond and for subsequent proton transfer reactions. Using these principles allows the rational design of electrocatalysts for H 2 oxidation using earth-abundant metals.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗
DOE OSTI2019

The Role of Excited State Proton Relays on the Photochemical Dynamics of Water Nanodroplets

In this work, we applied non-adiabatic excited state molecular dynamics in tandem with ab initio electronic structure theory to illustrate a complete mechanistic landscape underpinning the UV absorption initiated photochemical dynamics in water nanodroplets. The goal is to understand the nonequilibrium excited state molecular dynamics initiated by the relaxation of solvated photoelectron, and consequential photochemical processes. The lowest-lying excited state shows the proton dissociation for a single water molecule forming intermediate hydronium complexes through a proton relay. At approximately 100 femtoseconds, the proton relay process gives rise to the relaxation of the excited state accompanied with a rapid increase in the non-adiabatic coupling strength with the ground state, and the nanodroplet non-radiatively decays. The non-adiabatic transition to the ground state produces excited vibrational states that facilitate the recombination of the dissociated proton and hydroxyl group, eventually leading to the desorption of water molecules from the nanodroplet. Additionally, lifetimes of transient photochemical events are also resolved for the relaxation of solvated electron, excited state proton relay, and non-radiative transition.

Stetina, Torin F.↗